Literature DB >> 1612203

Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age.

K J Cruickshanks1, C M Vadheim, S E Moss, M P Roth, W J Riley, N K Maclaren, D Langfield, R S Sparkes, R Klein, J I Rotter.   

Abstract

It has been suggested that HLA-DR4 is a marker of genetic predisposition to proliferative retinopathy. To investigate this relationship and potential associations between other polymorphic genes and proliferative retinopathy, a sample (n = 428) of participants in the population-based Wisconsin Epidemiologic Study of Diabetic Retinopathy was selected for typing for HLA-A, -B, -C, and -DR and a panel of other polymorphic genes. The presence of proliferative retinopathy was determined from grading of stereoscopic color fundus photographs taken at 2 examinations, 4 yr apart. In logistic regression models with repeated measures, persons with HLA-DR4 who were negative for DR3 were five times more likely to have proliferative retinopathy than those negative for both antigens after adjusting for other potential risk factors (Odds ratio = 5.43, 95% Confidence Interval (Cl) = 1.04, 28.30). HLA-C2, AK-2, and MNSs-S also were associated positively with proliferative retinopathy, and HLA-DR8 was associated inversely with this complication of diabetes in each case before adjusting for the number of comparisons. These data suggest that the genetically determined immunopathic mechanisms leading to diabetes, and in linkage disequilibrium with DR4, may independently contribute to the development of proliferative retinopathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612203     DOI: 10.2337/diab.41.7.879

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  HLA typing is not predictive of proliferative diabetic retinopathy in patients with younger onset type 2 diabetes mellitus.

Authors:  T Mimura; S Amano; S Kato; M Araie; H Funatsu; S Kitano; E Shimizu; H Noma; O Yoshino; S Hori
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.

Authors:  A I Blakemore; A Cox; A M Gonzalez; J K Maskil; M E Hughes; R M Wilson; J D Ward; G W Duff
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

3.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

Authors: 
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

4.  Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; H Soomro; S Janikoun; R D Hollifield; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 5.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

6.  Genetic risk factors in diabetic retinopathy.

Authors:  L L Stewart; L L Field; S Ross; R G McArthur
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

7.  Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

Authors:  T S Kern; C M Miller; J Tang; Y Du; S L Ball; L Berti-Matera
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

8.  HLA class I and II alleles are associated with microvascular complications of type 1 diabetes.

Authors:  E M Lipner; Y Tomer; J A Noble; M C Monti; J T Lonsdale; B Corso; W C L Stewart; D A Greenberg
Journal:  Hum Immunol       Date:  2013-01-29       Impact factor: 2.850

9.  Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy.

Authors:  Michal Beránek; Petr Kolar; Svatava Tschoplova; Katerina Kankova; Anna Vasku
Journal:  Mol Vis       Date:  2008-06-14       Impact factor: 2.367

10.  Linkage Analysis of Genomic Regions Contributing to the Expression of Type 1 Diabetes Microvascular Complications and Interaction with HLA.

Authors:  Ettie M Lipner; Yaron Tomer; Janelle A Noble; Maria C Monti; John T Lonsdale; Barbara Corso; David A Greenberg
Journal:  J Diabetes Res       Date:  2015-10-11       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.